Canada Markets closed

THC Biomed Intl Ltd. (THCBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0727-0.0015 (-1.96%)
At close: 2:10PM EDT

THC Biomed Intl Ltd.

1340 St. Paul Street
Kelowna, BC V1Y 2E1
Canada

http://thcbiomed.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees45

Key Executives

NameTitlePayExercisedYear Born
Mr. John MillerPres, CEO & Director52.74kN/AN/A
Jung Chun HeeCo-Founder, CFO & Director52.66kN/AN/A
Mr. Damien ReynoldsChief Capital Markets OfficerN/AN/AN/A
Ms. Dianne Marie Szigety FCISCorp. Sec.N/AN/A1954
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.

Corporate Governance

THC Biomed Intl Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.